A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas

Cancer

Volumn 77, Issue 8, 1996, Pages 1501-1509

  Sonoda, Kenzo ^a   Nakashima, Manabu ^a   Kaku, Tsunehisa ^b   Kamura, Toshiharu ^b   Nakano, Hitoo ^b   Watanabe, Takeshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

flow cytometric analysis; immunohistochemical examination; monoclonal antibody; ovarian carcinoma; tumor associated antigen; uterine carcinoma

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; ENDOMETRIUM CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; UTERUS CARCINOMA; VAGINA DISCHARGE;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HEXOSAMINIDASES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEURAMINIDASE; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TRYPSIN; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0029966641     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1501::AID-CNCR12>3.0.CO;2-3     Document Type: Article

References (53)

1. Mueller BM, Romerdahl CA, Gillies SD, Reisfeld RA. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody. J Immunol 1990;144:1382-6.
2. Fung PYS, Madej M, Koganty RR, Longenecker BM. Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res 1990;50:4308-14.
3. Nelson KA, George E, Swenson C, Forstrom JW, Hellstrom KE. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells. J Immunol 1987;139:2110-17.
4. Kannagi R, Nudelman E, Levery SB, Hakomori S. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1. J Biol Chem 1982;257:14865-74.
5. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 1978;75:5565-9.
6. Miyake M, Zenita K, Tanaka O, Okada Y, Kannagi R. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res 1988;48:7150-8.
7. Itai S, Nishikata J, Takahashi N, Tanaka O, Matsubara Y, Hasegawa S, et al. Differentiation-dependent expression of I and sialyl I antigens in the developing lung of human embryos and in lung cancers. Cancer Res 1990;50:7603-11.
8. Itai S, Arii S, Tobe R, Kitahara A, Kim YC, Yamabe H, et al. Significance of 2-3 and 2-6 sialylation of Lewis A antigen in pancreas cancer. Cancer 1988;61:775-87.
9. Itai S, Nishikata J, Yoneda T, Ohmori K, Yamabe H, Arii S, et al. Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract. Cancer 1991;67:1576-87.
10. Leminen A, Paavonen J, Forss M, Wahlstrom T, Vesterinen E. Adenocarcinoma of the uterine cervix. Cancer 1990;65:53-9.
11. Angel C, Du Beshter B, Lin JY. Clinical presentation and management of stage I cervical adenocarcinoma: a 45 year experience. Gynecol Oncol 1992;44:71-8.
12. Yoshida K, Okuda H, Hayashi Y, Nakagiri Y, Sekiba K. A clinicopathological study on adenocarcinoma of the uterine cervix. Ada Obstet Gynecol Jpn 1991;43:261-5.
13. Tamini HK, Figge DC. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1982;13:335-44.
14. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-7.
15. Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nakano H, et al. Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995;6:1099-104.
16. Hinoda Y, Imai K, Endo T, Yamashita T, Yachi A. Detection of circulating adenocarcinoma-associated antigen in the sera of cancer patients with monoclonal antibody. Jpn J Cancer Res 1985;76:1203-11.
17. Herlyn M, Steplewski Z, Herlyn D, Koprowski H. CO 17-1A and related monoclonal antibodies: their production and characterization. Hybridoma 1986;5:S3-8.
18. Linnenbach AJ, Wojcierowski J, Wu S, Pyre JJ, Ross AH, Dietzshold B, et al. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci USA 1989;86:27-31.
19. Saga T, Ishiwata I, Endo K, Sakahara H, Koizumi M, Watanabe Y, et al. An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies. Jpn J Cancer Res 1990;81:1141-8.
20. Hsu S, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-21.
21. 111In-labeled monoclonal antibody 96.5. Cancer Res 1985;45:2376-81.
22. Halpern SE, Dillman RO, Witztum KF, Shega JF, Hagan PL, Burrows WM, et al. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report. Radiology 1985;155:493-9.
23. 111In-labeled T101 monoclonal antibody. N Engl J Med 1986;315:673-80.
24. 2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest 1986;77:301-11.
25. Koizumi M, Endo K, Watanabe Y, Saga T, Sakahara H, Konishi J, et al. Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma. Jpn J Cancer Res 1988;79:973-81.
26. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, et al. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci USA 1985;82:1242-6.
27. Irie RF, Morton DL. Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc Natl Acad Sci USA 1986;83:8694-8.
28. Nadler LM, Stashenko P, Hardy R, Kaplan WD, Button LN, Kufe DW, et al. Serotherapy of a patient with a monoclonal antiboy directed against a human lymphoma-associated antigen. Cancer Res 1980;40:3147-54.
29. Miller RA, Levy R. Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet 1981;1:226-30.
30. Nada A, Liwnicz B, Atkinson BF, Sela BA, Takahashi H, Belser PH, et al. Monoclonal antibodies with cytotoxic reactivities against human glioma. J Neurosurg 1989;71:892-7.
31. Takahashi H, Belser PH, Atkinson BF, Sela BA, Ross AH, Biegel J, et al. Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas. Neurosurgery 1990;27:97-102.
32. Noguchi A, Takahashi T, Yamaguchi T, Kitamura K, Takakura Y, Hashida M, et al. Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate. Jpn J Cancer Res 1991;82:219-26.
33. Kitamura K, Takahashi T, Yamaguchi T, Noguchi A, Noguchi A, Takashina K, et al. Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy. Cancer Res 1991;51:4310-5.
34. Takashina K, Kitamura K, Yamaguchi T, Noguchi A, Noguchi A, Tsurumi H, et al. Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol. Jpn J Cancer Res 1991;82:1145-50.
35. 131I LYM-I monoclonal antibodies. Int J Cancer Suppl 1988;3:96-101.
36. Bramwell ME, Ghosh AK, Smith WD, Wiseman G, Spriggs AI, Harris H. Ca2 and Ca3, new monoclonal antibodies evaluated as tumor markers in serous effusions. Cancer 1985;56:105-10.
37. Ferguson AM. The expression of Ca antigen in normal, hyperplastic and neoplastic endometrium. Br J Obstet Gynaecol 1984;91:1042-5.
38. Thor A, Viglione MJ, Murano R, Ohuchi N, Schlom J, Gorstein F. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynecol Pathol 1987;6:235-47.
39. Hilbone LH, Cheng L, Nieberg RK, Lewin KJ. Evaluation of an antibody to human milk fat globule antigen in the detection of metastatic carcinoma in pleural, pericardial and peritoneal fluids. Acta Cytol 1986;30:245-50.
40. McGee JO, Woods JC, Ashall F, Bramwell ME, Harris H. New marker for human cancer cells. Immunohistochemic detection of the Ca antigen in human tissues with the Ca 1 antibody. Lancet 1982;2:7-10.
41. Jha RS, Wickenden C, Anderson MC, Coleman DV. Monoclonal antibodies for the histopathological diagnosis of cervical neoplasia. Br J Obstet Gynaecol 1984;91:483-8.
42. Cohen C, Schulman G, Budgeon LR. Endocervical and endometrial adenocarcinoma. An immunoperoxidase and histochemical study. Am J Surg Pathol 1982;6:151-7.
43. van Nagell JR, Goldenberg DM. Carcinoembryonic antigen staining of endometrial and endocervical carcinomas. Lancet 1980;1:213.
44. Wahlstrom T, Korhonen M, Lindgren J, Seppala M. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histologic tissue specimens. Lancet 1979;2:1159-60.
45. Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB. Imunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Pathol 1983;79:98-104.
46. Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 1983;2:275-85.
47. Poropatich C, Nozawa S, Rojas M, Chapman WB, Silverberg SG. MSN-1 antibody in the evaluation of female genital tract adenocarcinomas. Int J Gynecol Pathol 1990;9:73-9.
48. Koizumi M, Ueda T, Shijubo N, Kudo R, Hashimoto M, Kikuchi K. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential. Cancer Res 1988;48:6565-72.
49. Dietel M, Arps H, Klapdor R, Muller-Hagen S, Sieck M, Hoffmann L. Antigen detection by the monoclonal antibodies CA19-9 and CA125 in normal and tumor tissue and patient' sera. J Cancer Res Clin Oncol 1986;111:257-65.
50. Neunteufel W, Bieglmayer C, Breitenecker G. CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading. Arch Gynecol Obstet 1988;244:47-52.
51. Scharl A, Crombach G, Vierbuchen M, Musch H, Bolte A. CA125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube: I. immunohistochemical detection. Arch Gynecol Obstet 1989;244:103-12.
52. Scharl A, Crombach G, Vierbuchen M, Gohring UJ, Gottert T, Holt JA. Antigen CA19-9: presence in mucosa of nondiseased mullerian duct derivatives and marker for differentiation in their carcinomas. Obstet Gynecol 1991;77:580-5.
53. van Nagell JR, Donaldson ES, Gay EC, Hudson S, Sharkey RM, Primus FJ, et al. Carcinoembryonic antigen in carcinoma of the uterine cervix: 2. tissue localization and correlation with plasma antigen concentration. Cancer 1979; 44:944-8.